Zorana Maravic speaking at the Amsterdam Biosimilar Medicines Conference – Digestive Cancers Europe
Digestive Cancers Europe shared a post on LinkedIn:
“DiCE CEO, Zorana Maravic speaking at the Amsterdam Biosimilar Medicines Conference!
Session 6: Turning Potential into Action – Biosimilar Repurposing and Combination Therapies
Recent advances in cancer therapies and patient outcomes have been realised. Effective cancer treatment increasingly involves targeting multiple pathways through combination therapies.
Biosimilar medicines have significant potential to enhance accessibility, reveal hidden therapeutic opportunities, and promote clinical research and innovation in cancer care.
Explore how biosimilar medicines can reshape accessibility and transform patient outcomes.”
Proceed to the video attached to the post.
More posts featuring Digestive Cancers Europe.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023